Holly Manning
Vice President of Investor Relations and External Communications
Replay available
Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call
Beam Therapeutics Inc. (NASDAQ: BEAM) Q4 2025 earnings conference call, held 2026-02-24. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Evans
Chief Executive Officer
Dr. Amy Simon
Chief Medical Officer
Dr. Gopi Shankar
Chief Scientific Officer
Dr. Kiran Musunuru
Professor of Cardiovascular Medicine, Genetics, and Pediatrics at the University of Pennsylvania; Co-Director of the Penn Orphan Disease Center
Shravan Amani
Chief Financial Officer
Dr. Giuseppe Pino-Ciaramella
President
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Beam Therapeutics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.356 Good morning and welcome to BEAM Therapeutics conference call. 00:00:04.356 -- 00:00:07.880 At this time, all participants are in a listen-only mode. 00:00:07.880 -- 00:00:10.983 There will be a question and answer session at the end. 00:00:10.983 -- 00:00:15.788 Please be advised that this call is being recorded at BEAM's request. 00:00:15.788 -- 00:00:21.314 I would now like to turn the call over to Holly Manning, Vice President of Investor Relations 00:00:21.314 -- 00:00:25.517 and External Communications. Please go ahead. 00:00:25.715 -- 00:00:29.920 Thank you, operator. Good morning, everyone, and welcome to BEAM's conference call to 00:00:29.920 -- 00:00:34.466 review updates announced this morning in conjunction with our fourth quarter and year-end 00:00:34.466 -- 00:00:39.553 2025 financial results. You can access slides for today's call by going to 00:00:39.553 -- 00:00:43.397 the investor section of our website, beamtx.com. 00:00:43.397 -- 00:00:48.824 With me on the call today with prepared remarks are John Evans, our Chief Executive Officer, 00:00:48.824 -- 00:00:52.249 Dr. Amy Simon, our Chief Medical Officer, Dr. 00:00:52.249 -- 00:00:57.461 Gopi Shankar, our Chief Scientific Officer, Shravan Amani, our Chief Financial 00:00:57.461 -- 00:01:01.886 Officer, and Dr. Kiran Musunuru from the University of Pennsylvania. 00:01:01.886 -- 00:01:06.432 Our President, Dr. Giuseppe Pino-Ciaramella, will join for Q&A. 00:01:06.432 -- 00:01:09.897 Before we get started, I would like to remind everyone that some of the statements we 00:01:09.897 -- 00:01:13.681 make on this call will include forward-looking statements for the purposes of the Safe 00:01:13.681 -- 00:01:19.208 Harbor provisions under the Private Securities Litigation...